Varenicline
- 1 July 2006
- journal article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 5 (7) , 537-538
- https://doi.org/10.1038/nrd2088
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Prevention of Relapse After Quitting SmokingArchives of internal medicine (1960), 2006
- Pharmacotherapy for Nicotine DependenceCA: A Cancer Journal for Clinicians, 2005
- Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking CessationJournal of Medicinal Chemistry, 2005
- Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and SensitizationScience, 2004
- Nicotine Dependence and Psychiatric Disorders in the United StatesArchives of General Psychiatry, 2004
- A Multiple Motives Approach to Tobacco Dependence: The Wisconsin Inventory of Smoking Dependence Motives (WISDM-68).Journal of Consulting and Clinical Psychology, 2004
- Estimates of global mortality attributable to smoking in 2000The Lancet, 2003
- Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotineNature, 1998
- Molecular and Cellular Aspects of Nicotine AbusePublished by Elsevier ,1996